LUNG · ISSUER CIK 1127537
Pulmonx Corp
Between Aug 1, 2026 and Oct 29, 2026, 4 Pulmonx Corp insiders reported $0.00 of open-market purchases and $177K of sales on SEC Form 4.
↗4 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 4 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$177KInsider selling
−$177KNet open-market
Sep 3, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 202618:23 | Sep 1, 2026 | LUNG | President and CEO, Director | S · Sell | $2.26 | −41,882 | 1,137,936 | -4% | −$95K | ||
| Sep 3, 202618:21 | Sep 1, 2026 | LUNG | Chief Science & Techn. Officer | S · Sell | $2.26 | −14,245 | 316,994 | -4% | −$32K | ||
| Sep 3, 202618:19 | Sep 1, 2026 | LUNG | General Counsel | S · Sell | $2.26 | −14,334 | 361,827 | -4% | −$32K | ||
| Sep 3, 202618:17 | Sep 1, 2026 | LUNG | Chief Commercial Officer | S · Sell | $2.26 | −7,879 | 449,832 | -2% | −$18K |